Literature DB >> 17454698

Depression during tobacco abstinence.

John R Hughes1.   

Abstract

Many clinicians and scientists believe smoking cessation increases the risk of major depressive disorder (MDD), especially among those with a past history of the disorder. This literature review located seven empirical tests of this belief. All seven had significant methodological limitations. The incidence of MDD over 7-64 weeks postcessation was 0%-14% among all smokers who tried to stop, 3%-24% among smokers with a past history of MDD who tried to stop, and 1%-31% among smokers who became abstinent. Smokers with a past history of MDD were more likely to have postcessation MDD. Although some within-study comparisons suggest abstinence increased the incidence of MDD, a definitive conclusion cannot be made. Whether treatment with antidepressants prevented postcessation MDD also was unclear. This review makes methodological recommendations for more definitive studies.

Entities:  

Mesh:

Year:  2007        PMID: 17454698     DOI: 10.1080/14622200701243185

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  32 in total

Review 1.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

Review 2.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

3.  The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey.

Authors:  Jae Cooper; Ron Borland; Hua-Hie Yong; Omid Fotuhi
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

4.  An algorithm for choosing among smoking cessation treatments.

Authors:  John Hughes
Journal:  J Subst Abuse Treat       Date:  2007-09-14

5.  Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Authors:  Serena Tonstad; Simon Davies; Martina Flammer; Cristina Russ; John Hughes
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

Review 6.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

7.  The Relationship between Smoking and Depression Post-Acute Coronary Syndrome.

Authors:  Andrew M Busch; Belinda Borrelli; Adam M Leventhal
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-02-01

8.  Tobacco Withdrawal Amongst African American, Hispanic, and White Smokers.

Authors:  Mariel S Bello; Raina D Pang; Karen L Cropsey; Michael J Zvolensky; Lorraine R Reitzel; Jimi Huh; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2015-10-18       Impact factor: 4.244

Review 9.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

10.  The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes.

Authors:  Wayne J Katon; Joan E Russo; Susan R Heckbert; Elizabeth H B Lin; Paul Ciechanowski; Evette Ludman; Bessie Young; Michael Von Korff
Journal:  Int J Geriatr Psychiatry       Date:  2010-05       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.